WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Disruptions of Brain Networks and Sleep by Electroconvulsive Therapy

Recruiting

Conditions: Treatment Resistant Depression

First Posted Date: 2023-06-15

Last Posted Date: 2023-11-24

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 50

Registration Number: NCT05905705

Locations: 🇺🇸
Washington University School of Medicine/Barnes-Jewish Hospital, Saint Louis, Missouri, United States

A Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia

Phase 2

Recruiting

Conditions: Endometrial Hyperplasia
Grade 1 Endometrial Cancer

Interventions: Behavioral: Telemedicine behavioral weight intervention
Behavioral: Enhanced usual care
Drug: Progestin
Drug: Levonorgestrel-releasing IUD.

First Posted Date: 2023-06-15

Last Posted Date: 2024-12-20

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 96

Registration Number: NCT05903131

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
🇺🇸
University of New Mexico, Albuquerque, New Mexico, United States
🇺🇸
University of Oklahoma, Oklahoma City, Oklahoma, United States

Fluvoxamine for Long COVID-19

Phase 2

Active, not recruiting

Conditions: Long COVID

Interventions: Drug: Fluvoxamine

First Posted Date: 2023-05-24

Last Posted Date: 2024-11-05

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 191

Registration Number: NCT05874037

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning

Recruiting

Conditions: Glioblastoma Multiforme

Interventions: Device: Support Vector Machine

First Posted Date: 2023-05-18

Last Posted Date: 2024-06-20

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 100

Registration Number: NCT05864976

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Personalized Tobacco Treatment in Primary Care (MOTIVATE)

Not Applicable

Recruiting

Conditions: Physician's Role
Smoking
Smoking Cessation

Interventions: Behavioral: Usual Care
Behavioral: Precision Treatment

First Posted Date: 2023-05-06

Last Posted Date: 2024-11-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 850

Registration Number: NCT05846841

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Brain Organization, Development, and Response to Intervention in Individual Neonates

Not Applicable

Not yet recruiting

Conditions: Development, Infant

Interventions: Behavioral: Neonatal Massage

First Posted Date: 2023-05-06

Last Posted Date: 2024-08-02

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 80

Registration Number: NCT05843396

Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders

Phase 2

Recruiting

Conditions: Schizophrenia
Treatment Resistant Depression
Aging, Premature

Interventions: Drug: Dasatinib + quercetin

First Posted Date: 2023-05-01

Last Posted Date: 2023-09-05

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 40

Registration Number: NCT05838560

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

CANF-Comb-II PET-MR in Atherosclerosis Multisite

Recruiting

Conditions: Carotid Atherosclerosis
Carotid Artery Atheroma
Asymptomatic Carotid Artery Stenosis

Interventions: Drug: 64Cu-25%-CANF-Comb

First Posted Date: 2023-05-01

Last Posted Date: 2024-05-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 80

Registration Number: NCT05838547

Locations: 🇺🇸
Cedars Sinai Medical Center, Los Angeles, California, United States
🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States

NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer

Phase 2

Recruiting

Conditions: Breast Cancer
Cancer of the Breast

Interventions: Device: VENTANA MIB-1 Ki67 assay
Device: Oncotype DX® Recurrence Score
Device: PAM50-based Prosigna breast cancer gene signature assay
Drug: Anastrozole
Drug: Combination anthracycline and/or taxane based treatment

First Posted Date: 2023-05-01

Last Posted Date: 2024-08-02

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 81

Registration Number: NCT05837455

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Palliative Spatially Fractionated (GRID) Radiotherapy Using Intensity Modulated Proton Therapy

Not Applicable

Recruiting

Conditions: Unresectable Solid Tumor
Metastatic Cancer

Interventions: Radiation: Proton GRID Radiotherapy

First Posted Date: 2023-04-26

Last Posted Date: 2024-04-29

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 20

Registration Number: NCT05831579

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy